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ABSTRACT 
 
Calcific Aortic Valve Disease (CAVD) is a major disorder in the developed 
countries among elderly. It is characterized by calcific deposition and stiffening of the 
aortic valve cusps. CAVD is a highly cell-mediated condition where valvular interstitial 
cells (VICs) become activated and differentiate into osteoblast-like cells. This is 
associated with upregulation of calcific markers like Alkaline phosphatase (ALP) and 
Runx2. ECM remodeling in another characteristic of stenotic aortic valves due to VIC 
activation. Reports show that CAVD initiates majorly on the noncoronary side of the 
aortic valves. Additionally, male sex is a significant risk factor of CAVD. Aortic valves 
are surrounded by a complicated hemodynamic environment. Pathological levels of 
mechanical forces applied to the aortic cusps interact with the VICs’ remodeling and 
differentiation and lead to abnormalities within the aortic cusps. 
In this dissertation, comparative studies were performed among VICs isolated 
from individual aortic cusps or between male and female to verify whether the 
differences in aortic calcification are observed at a cellular level. The calcification of 
VICs isolated from coronary and noncoronary aortic cusps was investigated in osteogenic 
culture condition to identify whether VICs show different amounts of calcific markers. 
Moreover, the osteogenic differentiation of VICs isolated separately from male and 
female aortic valves was analyzed to find if there are sex-related differences in their 
proliferation and calcification. Finally, both hypotheses were tested under cyclic strain to 
 v 
 
determine the impact of pathological vs. physiological strain on enhancing the VICs 
calcification among coronary and noncoronary cusps or between male and female valves. 
It was found that VICs isolated from noncoronary cusps demonstrated greater 
calcification potential than coronary cusps. Likewise, male VICs showed increased ECM 
remodeling compared to female. Pathological cyclic strain applied to VICs cultured in 
osteogenic condition enhanced their calcification, however VICs cultured in normal 
condition seem not to be affected by pathological cyclic strain. 
The results from this dissertation provide a new perspective on the biomolecular 
events associated with VICs calcification. It shows that VICs in different cusps of an 
aortic valve have heterogeneous populations. Furthermore, it confirms that sex of the 
cells matter in aortic valve calcification. 
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“There is still need to think and plan, but on a different scale, and along different lines.” 
C.S Forester (1899-1966), The Hornblower companion  
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CHAPTER ONE  
INTRODUCTION 
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Significance: 
For decades, Calcific Aortic Valve Disease (CAVD) was believed to be a passive 
degenerative condition. However, it is now well-accepted that CAVD is an active and 
highly cell-mediated process [1, 2]. This disease affects approximately 26% of the 
population over 65 years old and results in enormous cost for surgeries and medical care 
[3]. CAVD is a general term addressing all forms of aortic valve calcification including 
aortic sclerosis and stenosis. Aortic stenosis is the most prevalent heart valve disorder 
which in advance stages contributes to more severe heart disorders. Currently the only 
viable treatment for patients with major stenosis conditions is aortic valve replacement. 
Also, there is no method for early diagnosis and prevention of the disease progression. 
Every year 275,000 valve replacements are performed due to heart valve diseases 
worldwide with 82,000 replacements in only US [4]. With increasing number of patients 
with CAVD and complications associated with valve replacement and implant failure, 
there is a critical need to find an alternate treatment for CAVD. 
1.1 Aortic valve 
The aortic valve is located between the left ventricle and the ascending aorta. It 
prevents the blood backflow into the left ventricle during diastole. The aortic valve opens 
and closes about 40 million times per year and 3 billion times in an average lifetime. In a 
normal heart, the configuration of an aortic valve includes three cusps that attach to the 
aortic wall in a semilunar form, ascending to their commissures. Behind each cusp there 
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is a pocket called sinus of Valsalva. The aortic cusps are named with respect to their 
position toward the coronary arteries. The left and right coronary cusps face coronary 
inlets within their respective sinus of Valsalva whereas non-coronary faces no inlet. The 
microstructure of aortic cusps displays three different layers: Fibrosa on the aorta side in 
is the load-bearing component of the aortic valve with a network of collagenous crimps 
that enables valve opening in stress free condition; Spongiosa in the middle functions as a 
damper mostly consists of Glycosaminoglycans (GAGs), and Ventricularis facing the left 
ventricle with arranged elastin fibers with a small amount of collagen fibers (Figure 1.1) 
[5]. 
1.2 Valvular interstitial cells (VICs) 
The dominant cell population within the aortic heart valves is valvular interstitial 
cells (VICs). They are distributed non-uniformly among the aortic cusp layers with the 
highest density in fibrosa and the lowest in spongiosa. VICs are a heterogeneous 
population of fibroblasts with different sub-phenotypes. Overall, five distinct VIC 
phenotypes have been identified at different s conditions: eVIC (Embryonic Progenitor 
endothelial/ Mesenchymal Cells), qVICs (quiescent) , pVICs (mesenchymal progenitor), 
aVICs (activated) and obVICs (osteoblastic) [5]. Adult VICs are majorly quiescent 
fibroblasts with a limited population of  mesenchymal progenitor cells that have the 
capability of multiple lineage differentiation, most likely into myofibroblasts (activated) 
and osteoblast-like (osteoblastic) cells [6]. These two cell types are extensively seen 
within the diseased aortic valve transplants. Myofibroblasts are characterized by 
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significant expression of α-smooth muscle actin (α-SMA). Likewise, osteoblast-like VICs 
are characterized by osteogenic markers expression like alkaline phosphatase (ALP) [7]. 
 
 
Figure ‎1.1 Aortic cusp layers, rat aortic valve H&E staining 
 
1.3 Origin of the aortic valve 
During cardiogenesis, valves are formed in four stages: endocardial cushion 
formation, epithelial-to-mesenchymal transition (EMT), valve primordia, and 
diversification of cell types/maturation. Endocardial cushion is a mesenchymal outgrowth 
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that makes the aortic valve cusps, after the heart looping is completed. Notch1 signaling 
pathway is required for the endocardiac cushion development [8]. Neural crest cells 
(NCCs) in the endocardiac cushion regulate the outflow septation, the stage after which 
the aorta, pulmonary artery and the valves are formed [9]. NCCs are distributed among 
the aortic valve cusps during and after the septation. At the maturation stage of the valves 
that will result in diverse phenotypes of the valve cells, NNCs differentiate  into 
mesenchymal cells via a complex pathway that will ultimately lead to VICs within the 
aortic valves. However, a study showed that majority of NCCs are exclusively present in 
the aortic valve septal cusps which corresponds to left and non-coronaty cusps, 
suggesting that VICs in distal cusp which corresponds to right coronary might originate 
from another migratory embryonic cell type [10]. 
1.4 Calcific aortic valve disease (CAVD) 
CAVD is a highly cell-mediated disorder in which VICs become activated and 
contribute to the disease progression. CAVD is marked by calcific deposits within the 
aortic valve cusps. At the early stages of the disease or aortic sclerosis, inflammation and 
thickening of the cusps is noticed, whereas in advanced stage of the disease or aortic 
stenosis, large calcium nodules can be seen within the cusps (Figure 1.2). Although much 
remains to be learned about the etiology of CAVD, analyses of calcified human valve 
explants have identified number of effective characteristics of CAVD, such as: presence 
of inflammatory cells/molecules, angiogenesis, lipid deposition, extracellular matrix  
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disarray, elevated cellular migration, proliferation and apoptosis, and increased 
transforming growth factor- β (TGF- β1) expression [1, 11, 12]. 
 
 
Figure ‎1.2 Different stages of CAVD: sclerosis (left), stenosis (right) [2] 
 
Initiation of CAVD is related to trapping of low density lipoprotein (LDL) from the 
blood. Studies have shown that the proteoglycans within the aortic cusps are preferred 
sites for LDL accumulation. The entrapped LDLs transform into oxidatively modified 
LDL (oxLDL) and induce oxidative stress to the Valvular endothelial cells (VECs). This 
is followed by macrophage infiltration and activation [12] and release of  matrix 
degrading enzymes such as matrix metalloproteinase (MMPs) and their tissue inhibitors- 
tissue inhibitors of metalloproteinase (TIMPs)- and Cathepsin S [11, 13]. Abnormal 
extracellular matrix (ECM) degradation and synthesis activates the residing VICs which 
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is associated with increased secretion of osteogenic cytokines, most importantly ALP, 
TGF-β1 [14, 15] and bone morphogenetic protein-2 (BMP-2) [16, 17]. 
1.5 Sex/gender as a risk factor 
CAVD has number of identified risk factors such as age, male sex, smoking, 
hyperglycemia. Male sex is one of the most important risk factors for CAVDs; however, 
the molecular mechanisms that make male more susceptible to aortic valve complications 
are under investigated. Men have two fold excess risk of CAVD compared to women. 
Reports have shown that women, in general, develop CAVD 7-10 years later than men 
[18]. However, prevalence of CAVD increases drastically after menopause. It can be 
hypothesized that the loss of estrogen, which is an aspect of postmenopausal ovarian 
function, leads to cardiovascular dysfunction in older women [19, 20]. 
The sex difference in vascular disease is determined by the steroidal hormones and 
their cell receptors SSHRs. The biological process of steroidal hormones’ involvement in 
CVDs in general is complicated; both estrogen and testosterone receptors exist in 
cardiovascular cells. These receptors are members of the nuclear hormone receptor 
superfamily and can directly bind to DNA and regulate the expression of some adjacent 
genes, thus categorized as transcription factors [21].  
Not much is known about the pathological events of CAVD related to the sex at the 
cellular level. To our knowledge, sex steroid hormones’ effect on valvular tissue and cells 
in both sexes has not been reported. 
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1.6 Mechanical forces on valve calcification 
 Mechanical forces are an important component in the physiological microstructure. 
Aortic valve faces complex mechanical forces in each systolic cycle, including tensile 
stretch, bending stretch, fluid shear stress and varying pressures (Figure 1.3) [5]. During 
diastole, the tissue of the cusps is stretched via a backpressure. During systole, the cusp 
tissue becomes relaxed and shortens as a result of recoil of the elastin in ventricularis, 
which was elongated and taut during diastole. 
Consequently, the resident VICs are exposed to various mechanical forces exerted 
on valve tissue, most importantly tensile stretch [22]. Part of the tensile stretch enforced 
on VICs is due to the high blood overpressure in diastole, the other is due to outflow in 
systole when the cusps are subjected to high pulsatile shear stress. The VICs are designed 
to function under physiological mechanical forces. However, any abnormal changes in 
the mechanical forces experienced by the VICs will result in pathological condition, 
which leads to ECM remodeling and ultimately calcification [23]. Calcific deposits in 
aortic valve occur in the regions with the highest functional valve stresses [24]. The 
asymmetric configuration of a normal tricuspid aortic valve with coronary inlets in two of 
the three cusps, result in variation in mechanical forces experienced by different parts of  
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Figure ‎1.3 Aortic valve cusps subjected to different mechanical forces at each systolic 
cycle [1]  
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one aortic valve. Studies have confirmed that different parts of the aortic valve 
experience different amounts of mechanical force at each cycle [25, 26]. 
Studying the VICs’ behavior is essential for achieving a thorough understanding of 
the underlying events in stenotic conditions; however, this requires mimicking the 
mechanical forces experienced by VICs in vitro. This has been accomplished by 
commercial and custom-made bioreactors that can apply predefined physiological forces 
to cells and tissues in a laboratory culture environment.  
Flexcell
®
 system is a commercially available bioreactor designed to apply strain on 
the cultured cells in a sterile chamber to simulate the stretch. The system comprises of a 
base plate, pump, controller, computer and monitor, and culture plates (Figure 1.4). The 
culture plates are exclusive for this bioreactor, named Bioflex
®
 plates made of flexible 
bottom in their well. Various culture plate designs are available including uniaxial and 
circumferential strain plates. The software provided in the system is capable of applying 
different forms of strain on the well plates at varying extents. Moreover, the culture plates 
can be coated with different ECM proteins such as collagen I. 
Flexcell® bioreactor functions based on a simple model that incorporates applying 
a vaccum. The plates are fixed on their baseplates. A vacuum is attached to the baseplate 
pulling the outer ring of the cultured well and applying strecth to the inside area. 
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Figure ‎1.4 Flexcell® system components 
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CHAPTER TWO  
A REVIEW OF SEX-RELATED STUDIES ON MAJOR 
HEART VALVE DISEASES AND ATHEROSCLEROSIS 
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2.1 Introduction 
It is well accepted that there is difference in the prevalence and severity of major 
cardiovascular disorders among men and women. Male has been classically considered a 
risk factor in cardiac disorders. The molecular mechanism behind sex’s role in the 
initiation and progression of heart valve diseases and atherosclerosis has barely been 
investigated. 
In chapter 1, I presented the microstructure of the aortic valve. Three thin layers are in 
each aortic cusp (Figure 2.1A): Fibrosa in the aortic side consists of densely oriented 
fibers of type I and type III collagens; Spongiosa in the middle mainly consists of 
proteoglycans and glycosaminoglycans with some collagen fibers; and Ventricularis on 
the ventricular side  consists of a network of radially oriented elastin fibers [27]. In the 
mitral valve, the two leaflets are attached to the myocardial membrane by a series of 
tendon-like structures, called chordae tendinae (Figure 2.1B). The normal mitral leaflet 
layers are: Fibrosa, Spongiosa, and Atrialis facing the left atrium; whereas the chordae 
tendinae contains large number of longitudinally oriented collagen fibers [28]. 
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The blood vessel structure consists of three layers: Intima, a layer of endothelial 
cells in direct contact with the blood flow and an underlying connective tissue; Media, 
sheets of smooth muscles with connective tissues in between; and Adventitia, a layer of 
fibrous connective tissue covering the outermost part of the vessels (Figure 2.2 A,B) [29]. 
Previously, aortic valve stenosis was believed to be a passive condition resulted from 
atherosclerosis. This statement was due to numerous similarities between CAVD and 
atherosclerosis. The major similar characteristics of the two conditions include but not 
limited to: 
- Shared risk factors such as male sex, smoking, diabetes, hyperglycemia,.. 
- Calcium deposition within the tissue 
- Expression of similar enzymes and growth factors like ALP, BMPs, Osteopontin  
Previous studies compared the cultured VICs and vascular smooth muscle cells (VSMCs) 
differentiation and deformation in pathological conditions [30]. However, the sex-related 
cellular mechanism which expose male to excess risk have not been investigated in VICs 
and barely investigated in VSMCs. Similarly, no comparative sex-related study has been 
performed among heart valve disorders and atherosclerosis. The similar pathophysiology 
of these disorders motivated us to review previous sex-related studies on aortic stenosis, 
mitral valve prolapse and atherosclerosis.  
2.2 Aortic Stenosis 
Aortic stenosis refers to the deposition of calcium within the aortic valve tissue [5, 
6, 31]. Majority of early sex/gender-difference studies on aortic stenosis focused on the  
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Figure  2.1 (A) aortic cusp layers, (B) mitral leaflet layers, porcine aortic valves H&E 
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Figure ‎2.2 (A) Aorta cross-section, (B) vascular layers from aorta, rat H&E 
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effect of aortic stenosis on the myocardium, most importantly on left ventricular (LV) 
hypertrophy and LV degeneration, but not on the diseased aortic valve. For example, in a 
study by Carroll et al. on patients over 60 years with aortic stenosis, women’s LV 
response was more adaptive, while men’s cardiac performance (quantified by defined 
cardiac function indexes) was more frequently depressed [32]. Nordmeyer et al. 
investigated sex-dependent alterations in myocardial estrogen receptor and hypertrophy-
related gene expression in human aortic valve stenosis [33]. Estrogen receptors (ER) are a 
subgroup of Sex Steroid Hormone Receptors (SSHRs) expressed in mouse myocytes, 
fibroblasts, and human heart cells. The authors showed that α-ER and β-ER mRNA 
increased in human hearts with aortic stenosis. While α-ER mRNA content among men 
and women were comparable, β -ER mRNA content was significantly greater in women 
than men (47% vs. 28%) with respect to controls. This suggested a link between β-ER 
expression and greater aortic stenosis in women [33].  
Other studies measured sex difference in the biomolecular turnover in LV 
myocardium during aortic stenosis. Regitz-Zagrosek et al. reported that the overload 
pressure in left ventricle led to increased extracellular matrix (ECM) remodeling and 
collagen I, III, and fibronectin deposition in early stages of aortic stenosis [34]. Similarly, 
Skavdhal et al. studied the role of ER subtypes by inducing aortic stenosis condition in 
male and female mouse models [35]. They found that the female wild type mice had 
significantly lower induced hypertrophy in response to pressure overload as compared to 
male mice. Additionally, β-ER attenuated response to pressure overload in female mice. 
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[36].  More comprehensive discussion on LV pathophysiology and changes in myocytes 
due to hypertrophy and role of sex hormones can be found in excellent review by Regitz-
Zagrosek and Seeland [37].  
Even though majority of sex studies on aortic stenosis focused on the heart, 
Aggarwal et al. used multidetector CT imaging to evaluate the severity of aortic stenosis 
among men and women. They found that aortic valve calcification is significantly lower 
in women compared to men at all stages even after accounting for their smaller body size. 
This work, however, did not offer any information on impact of sex/gender on the 
pathogenesis of aortic stenosis [38]. Another study by McCoy et al. on aortic valvular 
interstitial cells identified 183 genes to be significantly different in male vs. female 
healthy porcine aortic valves, many of them relevant to pathways activated in HVD. They 
concluded that the greater occurrence of HVD in male may originate from their genetic 
propensity to develop HVD at the cellular scale [39]. Similarly, data from our laboratory 
(in chapter 4) indicate a difference in ECM remodeling and early calcific marker 
expression such as alkaline phosphatase, between male and female valvular cells derived 
from rats. With growing awareness on the role of sex in HVDs, we anticipate more 
research will elaborate on the sex-difference in aortic stenosis in the near future. 
2.3 Mitral Valve Prolapse 
Mitral valve prolapse (MVP) is often associated with a number of ruptured chordae 
tendineae, myxomatous thickening and tissue remodeling [40]. In advanced stages of 
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MVP, mitral regurgitation (MR) occurs with high possibility of heart failure. In fact, 
according to epidemiological studies, MR is the most common HVD [41, 42]. MR 
frequently occurs due to progression of myxomatous changes in valves with chronic 
prolapse conditions [43, 44].   
The major risk factor for myxomatous mitral valve disease is age; however, a few 
sex/gender-difference studies in humans or dogs are available. In one of the early studies, 
Lax et al. reported that mitral valve prolapse occurs more frequently in women by testing 
a hypothesis that mild dehydration induces mitral valve prolapse [45, 46]. The interesting 
observation in these studies was that 50% of the women showed MVP symptoms, 
whereas only 10% men were affected. Even after considering the anatomical differences 
between female and male mitral valve leaflets and annulus, it could be concluded that 
MVP induced by dehydration is more likely to happen in healthy women than in men. In 
contrast, a separate study performed on a population with different body habitus, Savage 
et al. showed no significant difference in mitral valve prolapse between female and male 
in asthenic patients [47]. In another study, Avierinos et al. used a population of male and 
female patients with different stages of MVP: no regurgitation, with mild prolapse, and 
moderate or severe regurgitation [48]. They also accounted for the number of surgeries 
and the mortality rate in male and female. They found that women had significantly 
greater number of anterior and bileaflet prolapse, leaflet thickening (32% vs. 28%), lower 
posterior prolapse (22% vs. 31%), flail (2% vs. 8%), and severe regurgitation (10% vs. 
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23%) than men (p<0.001). Therefore, they concluded that women had a higher likelihood 
of getting MVP and at a younger age than men. 
Sex and gender difference studies on MR have also been very limited; however, a 
few clinical studies have identified male [43, 49] or, female [50-53] as risk factors for 
MR. Singh et al. designed a clinical study with two groups of patients: one with severe 
MR due to MVP and a group of randomly selected patients with MVP [44]. Their 
findings showed a lower cumulative risk of surgery for women with MVP than men 
(0.8% vs. 2.6%) before age 65 and (1.4% vs. 5.5%) by age 75. In another population-
based study, Jones et al. studied various MR risk factors in American Indian population 
[54]. They divided the participants by MR severity level and concluded that MR is 
independently associated with female sex, lower body mass index, older age and renal 
dysfunction. Likewise, Wilcken et al. performed a cohort study on Australian men and 
women that were at risk of MVP [55], and combined that with a clinical study on patients 
that had mitral valve surgery due to myxomatous mitral disease. The goal of this study 
was to estimate the cumulative risk of developing severe MR due to MVP in men and 
women. Their result showed that before age 50, the risk was low in general; however, 
men over 50 were at an increased risk of MR. In all age groups (50s, 60s and 70s), the 
risk in women was less than half of that in men [43]. 
The contradicting results on the above population-based studies on MVP/MR are 
not surprising, since it is difficult to isolate other variables and risk factors in clinical 
studies. Perhaps studies on the cellular/molecular mechanisms in MVP could shed light 
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on the sex-difference in this disease. Unfortunately, the authors were surprised to see the 
lack of literature in this area. In fact, we found only one report by Grande-Allen et al. that 
studied the difference in the abundance of a major proteoglycan versican among the male 
and female patients with myxomatous disease. [56]. Sex-difference was apparent in both 
normal and myxomatous valves: in normal valves, versican amount was higher in female 
than in male; in myxomatous samples, versican was higher in male. In addition, when the 
abundance of total proteoglycan (Decorin, Biglycan and Versican) was measured in 
myxomatous valves, male showed a trend of greater total proteoglycan than female 
valves.  
2.4 Atherosclerosis 
Atherosclerosis is a chronic inflammatory disease with a similar mineralization 
process as aortic stenosis [57-59]. In later stages of atherosclerosis, vascular smooth 
muscle cells (SMCs) differentiate into osteoblast-like cells, and express proteins involved 
in bone formation, such as bone morphogenic protein (BMP)-2, osteopontin (OPN), 
matrix gla protein (MGP), and osteoprotegerin (OPG) [57]. A number of studies have 
reported some differences in the manifestations of atherosclerosis in male vs. female [58, 
60-62]. Even though majority of these studies were based on clinical or epidemiological 
data, some recent reports investigated role of biomolecular factors in sex-dependent 
behavior of SMCs in atherosclerotic condition. For example, reactive oxidative species 
(ROS) contributes to atherosclerosis by enhancing oxidative stress and apoptosis [63-65]. 
However, only a few studies have investigated the effects of sex on the oxidative stress in 
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isolated vascular SMCs. Malorni et al. exposed freshly isolated male and female vascular 
SMCs to UV radiation as oxidative stress inducer. They reported that male cells produced 
significantly greater amounts of hydrogen peroxide and superoxide anion, both important 
ROS molecules. Additionally, they showed that male cells had more cytoskeleton 
damage due to UV radiation, which might lead to their increased apoptosis [66]. In their 
recent study, they further analyzed female cells’ apoptotic resistance by studying their 
behavior in anoikis, a type of cell apoptosis, via detachment from substrate. Their results 
confirmed that number of detached cells in female were lower both prior to UV radiation 
and after radiation [67].  
 A series of studies have shown sex-dependent interactions between SMCs and 
Nitric Oxide (NO), a molecule known to inhibit the development of neointimal 
hyperplasia [68, 69] . Hogg et al. evaluated the efficacy of NO at inhibiting the vascular 
SMC proliferation, migration and cell cycle progression in vitro, as well as neointimal 
hyperplasia in vivo. They reported that NO effectively inhibited proliferation, migration 
and cell cycle arrest in both sexes; however, male SMCs showed stronger response in 
both hormone-replete and –deplete conditions than females. Similarly, their rat models 
treated with weight-dependent dosage of NO showed reduced neointimal hyperplasia in 
males than females. Furthermore, their rat models with carotid artery injury in 
hormonally intact or, castrated rats were in continuance with the in vitro study [68]. To 
determine the underlying causes for these sex differences, the authors further studied the 
role of ER on proliferation of male and female vascular SMCs following exposure to NO. 
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They observed that both α-ER and β-ER repressed proliferation in males, whereas only β-
ER was effective in females. Since NO signals through ERs, it was less effective in 
reducing neointimal hyperplasia in female [69]. 
Another marker OPN, a non-collagenous adhesive protein in bone matrix [57, 70], 
promotes atherosclerotic lesions in early stages, but inhibits mineral deposition in later 
stages by attaching to the apatite crystal and preventing its growth [58, 71, 72]. Using 
mice deficient in both OPN and apolipoprotein E, Matsui et al. showed that female wild 
type mice had significantly larger atherosclerotic lesions compared to the knockout mice, 
suggesting they are at greater risk for atherosclerosis. No notable difference among male 
mice genotypes was observed in their study [58].  
Other studies have focused on lipoprotein(a) [73, 74], a major risk factor for 
atherosclerosis and coronary heart disease [75]. High levels of plasma lipoprotein(a) 
correlate to early stages of coronary atherosclerosis predominantly in men [73, 74]. In a 
population-based study, Shreiner et al. compared plasma lipoprotein(a) levels to 
preclinical carotid atherosclerosis in middle-aged (45 to 64) white and black male and 
female patients by measuring their carotid wall thickness [73]. In this study, other risk 
factors such as smoking, diabetes and menopause were also considered. They reported 
that white men on average had the greatest mean carotid intimal-medial far-wall 
thickness among the four race/sex groups (0.798 mm compared to 0.779, 0.718, and 
0.695 mm in black men, black women, and white women, respectively). In Black women 
with diabetes, the lipoprotein(a) was significantly associated with wall thickness; 
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however, this association was not observed for non-diabetics. For white women, the 
association between lipoprotein(a) and wall thickness depended mostly on smoking status 
with nearly statistical significance. In general, they reported a correlation between 
lipoprotein(a) and carotid wall thickness in the preclinical atherosclerotic disease; 
however, this association was heavily affected by other risk factors. Nonetheless, in the 
absence of major risk factors, women had lower carotid wall thicknesses and lower 
amount of lipoprotein(a) in their blood compared to men. Stensland-Bugge et al. similarly 
employed ultrasonographic scanning to determine sex and age differences in carotid 
atherosclerosis by measuring carotid artery intima-media thickness [76]. Their results 
showed that in all age groups (25-40, 40-60, >60), men had a thicker mean intima-media 
layer than women, and this difference increased significantly with age. In addition, this 
study suggested fibrinogen as a strong risk factor in men than women. Another risk 
factor, physical activity, reduced the risk of cardiovascular disease in men, but had no 
significant effect on women [77]. When low, medium and high level of physical activity 
in each group was compared, medium physical activity had the most significant 
protective effect against CVD in men. Alternatively, a different study showed that low 
physical activity at work led to elevated incidents of stroke and death in women [78]. In 
another study by Stensland-Bugge et al., triglycerides strongly correlated with subclinical 
atherosclerosis in women than in men [76]. While previous studies have linked serum 
triglycerides levels and high-density lipoprotein  cholesterol [79-81], this study reported 
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that intima-media thickness and triglycerides in women was independent of high-density 
lipoprotein cholesterol levels [76]. 
2.5 Summary 
As reviewed in this chapter, male is a significant risk factor for CAVD and 
atherosclerosis. Comparatively, the sex-related investigations on the pathology of CAVD 
and atherosclerosis suggest similarities in the molecular events in the diseases initiation 
(endothelia cell activation) and progression (osteogenic differentiation and presence of 
osteoblast-like cells in calcific lesions). However, in mitral valve disorders females were 
reported to be at a higher risk. Table 2.1 summarizes the prevalence of the reviewed 
cardiovascular disorders among men and women. 
 
Table ‎2.1 Prevalence of Cardiovascular Diseases in Men and Women 
Disorder Male Female 
Aortic Stenosis A recognized risk factor Shows increased left 
ventricular hypertrophy 
after menopause 
Mitral Valve prolapse Increased ECM production Clinically at higher risk 
Atherosclerosis Greater risk in men Larger atherosclerotic 
lesion in OPN deficient 
female mice 
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CHAPTER THREE  
COMPARISON OF CALCIFICATION POTENTIAL OF 
VALVULAR INTERSTITIAL CELLS ISOLATED FROM 
INDIVIDUAL AORTIC CUSPS 
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Abstract: 
Calcific aortic valve disease (CAVD) is one of the most prevalent disorders among 
the elderly in the developed countries. CAVD develops via cell-mediated processes, and 
clinical data show that CAVD initiates mostly in the noncoronary cusp of the aortic 
valve. Valvular interstitial cells (VICs) populate the inside of heart valves and are a 
heterogeneous cell population. The goal of this study is to elucidate the difference in 
calcification potential among VICs isolated from the left, right, and noncoronary cusps of 
porcine aortic valves. 
VICs were isolated from each of the aortic valve cusps and cultured in calcifying 
medium for 14 days to induce calcification. The samples were assessed for calcium 
deposits, nodule formation, and calcific markers using alizarin red and Von Kossa 
staining, alkaline phosphatase (ALP) staining, ALP enzyme activity assay, and western 
blot. Extracellular matrix (ECM) production and degradation was measured using 
collagen and glycosaminoglycan (GAG) assay and gelatin zymography. We observed 
that VICs isolated from the noncoronary cusp expressed greatest amount of the above 
calcific markers as compared to the coronary cusps. Also, collagen and GAG content was 
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the greatest in noncoronary VICs. However, our zymography results showed significant 
difference only for active Matrix metalloproteinase-2 (MMP-2) expression between right 
and noncoronary VICs. 
Our results suggest that VICs among the three cusps within aortic valve might be 
inherently different, where a subpopulation of VICs might be predisposed to 
calcification. 
Keywords: Calcific aortic valve disease, coronary and noncoronary cusps, valvular 
interstitial cells, calcification 
 
3.1 Introduction 
Calcific aortic valve disease (CAVD) refers to a major disorder ranging from mild 
inflammation within the aortic valve cusps (aortic sclerosis) to severe calcific nodule 
formation in the aortic valve tissue (aortic stenosis) [5]. These two conditions affect 26% 
and 2% of the population over 65 years in the developed countries, respectively [3, 4, 
82]. End-stage aortic stenosis is associated with life-threatening outcomes, such as left 
ventricular hypertrophy [83, 84]. Unfortunately, the underlying events associated with the 
initiation and progression of CAVD is not fully understood.  
It has been reported that CAVD is a highly active condition mediated by valvular 
interstitial cells (VICs), the dominant cell population in heart valve tissue. In the aortic 
valve, VICs are distributed non-uniformly among the three valve layers—the 
ventricularis, fibrosa, and spongiosa—the fibrosa layer has the highest and spongiosa 
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layer the lowest cell density [1]. Numerous studies have shown that VICs have a 
heterogeneous cell population among the four heart valves and also in different locations 
within each valve [5, 7, 85, 86]. VICs were initially believed to mainly consist of 
fibroblast and myofibroblast characteristics [7, 87]. Recently, VICs have been 
categorized into a major population of quiescent VICs with a small subpopulation of 
progenitor VICs and osteoblast-like VICs [7].  The mesenchymal progenitor VICs have 
limited self-renewal ability when activated (aVICs) that may contribute to valve repair in 
injuries [6]. On the other hand, in calcifying conditions, VICs differentiate into 
osteoblastic VICs (obVIC). aVICs display features of myofibroblasts, while obVICs 
show characteristics of osteoblasts, or bone-like cells [88, 89]. The calcification of VICs 
in the presence of organic phosphate in culture occurs due to the upregulation of alkaline 
phosphatase enzyme. VICs also express hydroxyapatite in calcified nodules similar to the 
bone formation process [90]. 
The normal tricuspid aortic valve has two cusps with coronary inlets—left and right 
coronary cusps—that are connected to the left and right coronary arteries and are 
responsible for the blood supply to the heart muscle. The other cusp with no coronary 
inlet is referred as noncoronary cusp. This asymmetric configuration of the tricuspid 
aortic valve incurs different blood backflow pressure or possibly localized turbulence on 
the coronary and noncoronary cusps during the end diastolic cycle. In CAVD, the 
noncoronary cusp is often the first cusp affected with aortic lesions [2], and its stenotic 
area is larger than that of the other coronary cusps [91]. While the reason behind this 
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difference in calcification is mostly unknown, since VICs are sensitive to their 
mechanical environment, the non-uniform mechanical forces suggest that a 
heterogeneous cell population would exist in these cusps. 
The goal of this study is to assess the inherent cellular heterogeneity among the aortic 
valve cusps by quantifying VICs’ osteogenic properties in response to biomolecular 
factors in culture. We hypothesized that VICs residing in each of the aortic cusps have 
intrinsically different characteristics, where VICs isolated from the noncoronary cusp 
would calcify more than the coronary cusps.  
3.2 Materials and Methods 
3.2.1 VIC Isolation and Culture 
Aortic valves were removed from freshly sacrificed four to six year old female 
porcine hearts obtained from Wampler’s Farm Sausage, Inc., Lenoir City, TN. Each of 
the aortic valve cusps were removed, finely chopped, and incubated in collagenase II 
digestion solution (15000 U/ml) for 4 hours. The cells were cultured in growth media 
consisting of DMEM, 10% FBS, 1% L-glutamine, and 1% Penicillin/Streptomycin (all 
purchased from Mediatech, Inc., Manassas, VA) at 37
o
C and 5% CO2. All cells were 
passaged at 90% confluency and used for experiments at 4 passages. VICs were isolated 
from four different porcine valves (n=4). 
Unless otherwise specified, the VICs isolated from each of the left, right and 
noncoronary cusp were seeded onto 6-well plates at a density of 250,000 cells/well. 
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Osteogenic media consisted of 2.18 g/L beta-glycerophosphate, 50 mg/L L-ascorbic acid 
2-phosphate and 1mM dexamethasone (all purchased from Sigma, St. Louis, MO) added 
to regular media. Experimental samples were cultured in osteogenic media, where the 
control wells were cultured in regular media.  
Culture duration was determined by preliminary studies in which the VICs were 
cultured in osteogenic media for different time points ranging from 4 to 20 days. We 
noticed the VICs expressed strongest osteogenic markers at day 14, whereas by 20 days, 
we observed increased cell monolayer detachment possibly due to cell apoptosis. As a 
result, we selected day 14 as the longest calcification duration for this study. Further 
experiments were performed at 4, 7, 10, and 14 day time-points. 
3.2.2 Hematoxylin & Eosin (H&E) Staining of Tissue Sections 
Freshly isolated aortic valve cusps were fixed in 10% formalin, paraffin embedded, 
and sectioned using established histology procedure [92]. The tissue sections were 
stained with Hematoxylin 2 for 5 minutes and Eosin Y for 1 minute, both purchased from 
Richard-Allen Scientific, Kalamazoo, MI. The stained sections were imaged using a 
brightfield microscope, and the width of the imaged sections was measured using ImageJ 
software (NIH). 
3.2.3 DNA Content Quantitation 
The cell density for VICs isolated from the coronary and noncoronary cusps were 
measured using a DNA assay [92]. Briefly, the cell monolayers were scraped from each 
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of the wells of 6-well plate and washed with phosphate buffered saline (PBS) and 
digested in Proteinase-K solution (1mg/mL) (Sigma). The cell lysates were vortexed and 
then incubated at a temperature between 60
o
C and 70
o
C for 90 minutes in a water bath 
and then heated at >70
o
C for 30 minutes to denature the Proteinase-K. Released DNA 
was tagged with Hoechst 33258 dye (Sigma) and fluorescence emission was measured 
using a BioTek H1 flourocolorimeter at 458 nm. Calf thymus DNA standards (Sigma) 
were used in each assay to calculate DNA density. 
3.2.4 Von Kossa and Alizarin Red Staining of Cultured VICs 
The amount of mineral deposition of cultured VICs isolated from each aortic valve 
cusp was determined using Von Kossa staining [30]. The cell monolayers in each well 
were fixed in 10% formalin (Fisher Scientific, Fair Lawn, NJ). A silver nitrate (Ricca 
Chemical Co., Arlington, TX) solution (3%) was added to the fixed cells, incubated and 
then exposed to UV until the calcium salts turned dark brown or black. The undissolved 
salts were removed using a 5% sodium thiosulfate (Sigma) solution and dehydrated with 
Flex before imaging. 
The calcium precipitation and nodule formation of the calcified VICs were assessed 
using alizarin red S staining [93]. First, the VICs were fixed with 10% formalin and 
treated with alizarin red solutions at room temperature for 4 to 5 minutes. The excess dye 
was washed off, and then the VICs were dehydrated with 100% acetone for less than 1 
minute. The stained samples were finally imaged at 10X magnification; image analysis 
was performed using ImageJ software. 
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For image analysis, a number of 30 to 40 images per well were imported into Image 
J. The color channel on each image was split, and the threshold was adjusted to form a 
black and white image. Finally, the area, area fraction, integrated density, and perimeter 
of each image were measured. 
3.2.5 Calcium Assay 
To measure the calcium content [30], the VICs  were homogenized in 1N acetic 
acid, and arsenazo dye was added to the samples. The calcium content was measured 
against calcium standard (Ricca chemical, Arlington, TX), and the resulting absorbance 
was detected at 650 nm using a BioTek H1 plate reader. The calcium content was 
normalized to total DNA content. 
3.2.6 Alkaline Phosphatase (ALP) Staining and Enzyme Assay 
The VICs were stained for ALP using a kit (Sigma) following manufacturer’s 
instruction. Briefly, the VICs were fixed with citric acid, 99% methanol and 10% 
formalin. The VICs were then incubated in the FRV-alkaline dye and hematoxylin for 15 
minutes each. The number of stained cells and total number of cells were counted using 
the particles analyzing tool in Image J software.  
To measure the ALP enzyme activity [93], the cultured VICs were rinsed with PBS, 
then each well was scrapped into 700μL RIPA lysis buffer and sonicated. The ALP 
enzyme in the samples was measured against standards prepared from 50 μM p-
Nitrophenol solution. A solution of 221 alkaline buffer (2-Amino-2-methyl-1-propanol, 
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1.5mol/L, Sigma) and phosphatase substrate (p-Nitrophenyl phosphate, disodium, Sigma) 
was added to the samples and incubated for 30 minutes at 37
o
C. The reaction was stopped 
using 1mM sodium hydroxide solution and the absorbance was measured at 405 nm 
using a BioTek H1 plate reader. The ALP amount in each sample was normalized to the 
total protein content. The total protein content was determined using Pierce BCA Protein 
assay kit (Thermo Scientific). 
3.2.7 Glycosaminoglycan (GAG) Content 
The VICs and lyophilized aortic valve cusp tissue samples digested in Proteinase-K 
solution were used to measure GAG content [30]. Dymethylmethylene blue (DMMB) 
dye was added to the samples, and the resulting absorbance was measured at 525 nm. The 
total GAG content in each sample was determined against chondroitin sulfate standards 
and normalized to total DNA content. 
3.2.8 Collagen Content 
The collagen type I content was measured using a sirius red assay. The VICs were 
digested in proteinase-K, and the lyophilized cusp tissues were digested in pepsin (Fisher 
Scientific). The samples were incubated with a sirius red dye (TCI, Portland, OR) 
solution (0.3 mg/ml, in 0.5M acetic acid) and then centrifuged at 6000 rpm for 30 
minutes. The supernatant was carefully collected from each sample, and the absorbance 
was measured at 540 nm using a BioTek H1 plate reader. The collagen content was 
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measured against standards prepared from bovine dermal collagen type I (MP 
Biomedicals, Solon, OH) and normalized to total DNA content. 
3.2.9 Gelatin Zymography 
Gelatin zymography was used to determine the amount of matrix metalloproteinase 
(MMP)-2, 9 enzyme produced within the cultured cell monolayers [30]. Briefly, equal 
amounts (5 mg of protein) of non-reduced samples were loaded into 10% zymogram gels. 
After electrophoresis, the gels were shaken in a renaturing buffer for 30 minutes and 
cleared overnight in developing buffer at 37
o
C  (Life Technologies, Grand Island, NY). 
The gels were then stained using colloidal blue staining kit (Life Technologies) and 
destained in 30% ethanol/10% acetic acid for 30 minutes, followed by a rehydration cycle 
in 2% acetic acid for at least 15 minutes. The gels were imaged using a Biorad ChemiDoc 
XRS imager, and the band densities were calculated using gel analysis tool in Image J 
software. 
3.2.10 Western Blotting 
The cell pellet was collected in a similar manner as described in DNA assay and 
digested in RIPA buffer containing protease inhibitor. The protein concentrations were 
measured using Pierce BCA protein assay kit (Thermo Scientific). Equal amounts (5 mg 
of protein) of samples were run on the acrylamide gels and transferred into nitrocellulose 
membranes (A&B biosystems). The protein bands were detected using Runx2 antibody 
(Santa Cruz Biotechnology Inc., Santa Cruz, CA) and loading control actin (1-19) (sc-
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1616) (Santa Cruz Biotechnology Inc.). The secondary antibody was donkey polyclonal 
secondary antibody to rabbit IgG- HPR (ab6802) (Abcam Inc., Cambridge, MA). The 
bands were detected using a western blot chemiluminescence detection kit (Fisher 
Scientific). The membranes were imaged using a Biorad ChemiDoc XRS imager, and the 
band densities were calculated using gel analysis tool in Image J software. 
3.2.11 Statistical Analysis 
Each experiment was repeated for four different cell isolations (n=4). The most 
significant difference was seen after 14 days of culture in almost all of the experiments; 
therefore, the plots are presented only for day 14 for the majority of the measurements. 
Statistical significance for the different experiments was obtained using single-factor 
ANOVA. A p-value of ≤0.05 was considered significant. 
3.3 Results 
H&E images of healthy porcine aortic valve tissue sections did not show any 
visible difference in composition among the three cusps (Fig. 3.1A,B,C). Similarly, no 
significant difference was observed in the thickness of the cusps (0.1579, 0.1584, 0.1595 
cm for left, right and noncoronary respectively, Table 3.1) measured using Image J 
software. Furthermore, no significant difference was observed in collagen and GAG 
content among the healthy porcine aortic valve cusps (Fig. 3.1D,E). 
 
 37 
 
Table 2.1 Tissue section thickness of the porcine aortic cusps 
Aortic valve cusp Left Right Noncoronary 
Average thickness (cm) n=3 0.1579 0.1584 0.1595 
 
 
3.3.1 Comparable Cell Density in VICs Isolated from Coronary and 
Noncoronary Aortic Cusps 
There was no significant difference in DNA content for VICs isolated from the 
cusps at the different time points. As shown in Fig.3.2, DNA concentration and fold 
change normalized to respective controls was comparable after 14 days of osteogenic 
culture for the VICs isolated from each of the aortic cusps. 
3.3.2 Elevated Osteogenic Marker Expression in VICs Isolated from 
Noncoronary Aortic Cusps 
Von Kossa staining of the VICs isolated from all three cusps demonstrated 
calcification in the cell monolayers under osteogenic condition compared to respective 
controls. The calcified area percentage and integrated density were significantly greater 
for the VICs isolated from the noncoronary cusp than for the left or right coronary cusps 
after 14 days of culture (Figure 3.3e,f). Furthermore, the amount of calcification 
increased with culture duration in osteogenic media in VICs isolated from all aortic 
cusps. 
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Figure ‎3.1 H&E staining of paraffin-embedded healthy porcine aortic valve cusp 
sections: (A) left, (B) right, and (C) noncoronary cusp. Parts D and E shows collagen and 
GAG content for the three cusps measured using a collagen and a GAG assay. No 
significant difference was observed in the thickness, collagen, and GAG content among 
the cusps. The data represent mean ± std. error, n=3 porcine aortic valves. Scale bar is 
250 μm. 
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Figure ‎3.2 DNA content measured using a DNA assay: (A) DNA concentration for VICs 
isolated from left, right, and noncoronary aortic cusps at day 14 of culture in regular and 
osteogenic media, and (B) fold change for the above VICs in osteogenic culture 
normalized to their respective controls. The data represent mean ± std. error, n=4 porcine 
aortic valves. 
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Figure ‎3.3 Images of Von Kossa stained VIC samples isolated from (A) left coronary, (B) 
right coronary, and (C) noncoronary aortic cusps cultured in osteogenic media for 14 
days; scale bar is 250 μm. (D) shows mineral deposition for a representative nodule from 
left, right and noncoronary cusps (left to right); scale bar is 100 μm. Image analysis 
results show (E) the area fraction and (F) integrated density of mineral deposition in VICs 
isolated from each aortic cusp after 4, 7, 10, and 14 days of culture in osteogenic media. 
The data represent mean ± std. error, n=4 porcine aortic valves. ⃰ indicates p<0.05 
compared to left coronary and # indicates p<0.05 compared to right coronary at the same 
time point. 
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Alizarin red S staining of the calcific nodules in VIC monolayers demonstrated that 
there were differences in the area percentage, integrated density, and size of the calcific 
nodules in the VICs isolated from each aortic cusp. The noncoronary and right coronary 
cusps showed significantly greater area fraction and nodule size compared to the left 
coronary after 14 days of culture in osteogenic condition (Figure 3.4g,h).For integrated 
density, the only significant difference was for noncoronary cusp when compared to the 
left coronary (Figure 3.4i). Furthermore, the size of the calcific nodules increased with 
culture duration for all of the aortic cusps. Not unexpectedly, as the nodules fused with 
each other and grew bigger, their number went down in most cases. 
The calcium content normalized to respective controls was significantly greater for 
VICs isolated from noncoronary aortic cusp than left and right coronary cusps after 14 
days of culture in osteogenic condition (Figure 3.5).  
ALP staining of the VICs in osteogenic culture showed positive staining from day 7 
onwards, and maximum number of ALP positive cells was observed by day 14 (Figure 
3.6 A,B). No ALP positive staining was detected in the control wells at any time point. At 
day 14, the % ALP positive cell was significantly greater for VICs from noncoronary 
cusp than those from either left or right coronary cusp (Figure 3.6C). Similarly, the ALP 
enzyme activity increased in all VICs when cultured for longer than 7 days in osteogenic 
condition as compared to their respective controls (data not shown). Additionally, the  
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Figure ‎3.4 Nodule formation measured by alizarin red staining in VIC samples isolated 
from (A, D) left coronary, (B, E) right coronary, and (C, F) noncoronary aortic cusps 
cultured in osteogenic media for 10 and 14 days respectively. Scale bar is 250 μm. Image 
analysis results show (G) the nodule  area fraction, (H) nodule perimeter, and (I) nodule 
integrated density in VICs isolated from each aortic cusp after 4, 7, 10, and 14 days of 
culture in osteogenic media. The data represent mean ± std. error, n=4 porcine aortic 
valves. ⃰ indicates p<0.05 compared to left coronary and # indicates p<0.05 compared to 
right coronary at the same time point. 
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Figure  3.5 Fold change in the calcium, GAG, and collagen I content for VICs isolated 
from left, right, and noncoronary cusps normalized to their respective controls at 14 days 
of culture in osteogenic media. Noncoronary VICs showed significantly greater calcium, 
GAG, and collagen I content compared to the coronary VICs. The data represents mean ± 
std. error, n=4 porcine aortic valves. ⃰ indicates p<0.05 compared to left coronary and # 
indicates p<0.05 compared to right coronary. 
 
 
normalized ALP activity was significantly elevated for VICs isolated from noncoronary 
cusps with respect to the left and right coronary cusps at day 14 (Figure 3.6D). 
Similar to ALP, Runx-2 expression, measured using western blot and normalized to 
housekeeping marker β-actin and then to respective controls, was significantly greater in 
VICs from the noncoronary cusp than from the coronary cusps after 14 days of culture 
(Figure 3.7A,B). 
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Figure ‎3.6 ALP staining and enzyme activity measurement in VICs: (A) Images of ALP 
positive VIC samples isolated from left coronary, right coronary, and noncoronary aortic 
cusps cultured in osteogenic media for 7,10,14 days; scale bar is 200 μm (B) 
Representative image of stained cells for image analysis; scale bar is 50 μm (C) Percent 
of ALP/TNAP positive VICs at days 7, 10, and 14 of osteogenic culture. (D) Fold change 
in the ALP enzyme activity at day 14 of osteogenic culture normalized to respective 
controls. The data represents mean ± std. error, n=4 porcine aortic valves. ⃰ indicates 
p<0.05 compared to left coronary and # indicates p<0.05 compared to right coronary. 
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Figure ‎3.7 Runx2 expression in VICs isolated from left, right, and noncoronary aortic 
cusps at 14 days of culture. (A) Representative image of bands for Runx2 and β-actin 
(control) for VICs isolated from one porcine aortic valve. For each cusp, samples 1 and 2 
were cultured in osteogenic media and control was cultured in regular media. (B) Image 
analysis of the bands at day 14 of culture. The data represent mean ± std. error, n=2 
porcine aortic valves. ⃰ indicates p<0.05 compared to left coronary, ♦ indicates p=0.05 
compared to right coronary.  
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3.3.3 Elevated Matrix Remodeling in the Calcified Cells 
The total GAG content normalized to respective controls was significantly greater 
for VICs isolated from noncoronary aortic cusp than left and right coronary cusps after 14 
days of culture in osteogenic condition (Figure 3.5). The difference in normalized GAG 
content was greatest at day 14 than for earlier time points for the noncoronary cusp as 
compared to the coronary cusps (data not shown for earlier time points). Similarly, 
collagen I content normalized to respective controls at day 14 was significantly greater 
for the noncoronary cusp as compared to the coronary cusps. 
Gelatin zymography showed that VICs in both osteogenic and regular media 
expressed inactive (pro) MMP-2; however, activated MMP-2 was observed only in VICs 
cultured in osteogenic condition. Figure 3.8A shows a representative image of the active 
(bottom white lines) and inactive (top lines) MMP-2. Image analysis of the bands showed 
that the VICs isolated from noncoronary aortic cusps demonstrated significantly elevated 
amount of active MMP-2 enzyme as compared to the right coronary cusp; however, 
active MMP-2 amount in the noncoronary cusps was not significantly elevated when 
compared to the left coronary cusp (Figure 3.8B). Similarly, no significant difference was 
obtained for the inactive and total MMP-2 content among the VICs from any of the 
groups. The bands for MMP-9 were not detectable in this study. 
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Figure  3.8 MMP-2 expression (active, inactive, total) detected by gelatin 
zymography for VICs isolated from left, right, and noncoronary at 14 days of culture. (A) 
Representative gel image for VICs isolated from left, right, and noncoronary cusps from 
the same porcine aortic valve. (B) Image analysis of the bands for VICs isolated from 
each aortic cusp at day 14 of culture. The data represent mean ± std. deviation, n=4 
porcine aortic valves. # indicates P<0.05 compared to right coronary. 
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3.4 Discussion 
In the present work, we observed a correlation between the location of the VICs 
within aortic valve cusps and the events associated with the initiation of calcification 
when cultured in pathological conditions. There was no significant difference in tissue 
thickness, collagen, and GAG content among the three cusps of healthy porcine aortic 
valves used for VIC isolation. The primary outcomes of this research are that VICs 
isolated from the noncoronary aortic cusp expressed a greater amount of calcific markers 
(ALP), osteogenic differentiation (Runx2), and mineralization when compared to left and 
right coronary cusps after 14 days of culture in osteogenic condition. Moreover, no 
significant difference in the normalized DNA content was noticed among the VICs, 
inferring that the observed difference in calcific markers and mineralization among the 
cusps was not due to a larger cell density. Our results suggest that there might be an 
inherent difference in VICs’ characteristics isolated from noncoronary and coronary 
cusps that initiates calcification earlier than other cell population. 
Numerous reports suggest that the noncoronary cusp is affected first during CAVD. 
The difference in calcification among aortic cusps has been studied clinically using 
echocardiography [94, 95] or CT imaging [26, 96] on stenotic patients. It was reported 
that the location of noncoronary cusp commissure correlates to the highest pressure 
overload or calcium deposition. An attempt to detect difference in early-stage 
calcification between the coronary and noncoronary cusps has been performed by Cujec 
and Pollick [95]. They reported that isolated thickening of a single aortic cusp was 
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frequently seen in the noncoronary cusp and rarely seen in the left coronary cusp. In 
another work, the calcified aortic cusps were weighted separately in valve transplantation 
patients, and the most frequent case reported was that one cusp was heavier with the other 
two having similar weights. However, they did not clarify which cusp had more weight 
[97].  Recently, a new study measured the calcific volume using the CT method in 
severely calcified cusps and showed that on average, the noncoronary cusps had greater 
volume of calcification than the left and right coronary cusps [96]. 
Ectopic aortic calcification is associated with expression of osteogenic and matrix 
remodeling markers. In pathological conditions, VICs form osteogenic nodules with 
increased mineralization and ALP enzyme activity [31, 90, 98]. Our study showed that 
the area covered and average size of the calcific nodules were not similar for VICs 
isolated from all cusps—the noncoronary VICs demonstrated the greatest % area and 
perimeter of nodules. Similarly, the integrated density analysis of the nodules 
demonstrated the greatest mineralization in noncoronary cusps. To support these 
observations, the calcium content was greatest for the VICs from noncoronary cusp by 14 
days of osteogenic culture. Aortic calcification is associated with bone formation via 
osteogenesis [99]. The VICs under osteogenic culture condition differentiated into 
osteoblast-like cells [6], as is found in human calcified aortic valve tissues [100]. Since 
calcific nodules contain osteoblast-like VICs, it can be inferred that noncoronary cusps 
has an elevated number of differentiated VICs and a propensity for active bone 
formation. Osteogenic nodule formation is marked with significant amount of ALP 
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enzyme within the calcific deposits [13]. In our study, we observed that the amount of 
ALP and percent ALP positive cells were significantly greater in noncoronary VICs than 
in the left and right coronary cusps by day 14 of culture. Likewise, Runx-2 expression 
was significantly enhanced in VICs from noncoronary than for coronary cusps at 14 days 
of culture, suggesting osteoblast-like differentiation is ongoing at different levels in the 
VICs. Interestingly, we noticed positive Runx-2 band in a few of the control western blot 
samples, even though the control samples did not stain positive in von kossa or alizarin 
red. Since VICs have been reported to spontaneously calcify [101, 102], it is possible that 
some of the VICs in control samples were also undergoing osteogenic differentiation.  
Calcific aortic valves show major ECM remodeling and abnormal activation of 
MMPs, a family of zinc-containing matrix enzymes that cleave various ECM 
components. An abundance of active MMP-2 enzyme among VICs is an early marker of 
matrix remodeling in aortic valve cusps [13, 103]. In our study, increased collagen I was 
synthesized by noncoronary VICs in osteogenic culture compared with left and right 
coronary. Furthermore, we observed a trend of increased active MMP-2 in VICs isolated 
from the noncoronary cusps in osteogenic culture after 14 days compared to left and right 
coronary cusps, indicating elevated matrix remodeling in noncoronary cusps. However, 
the trend for total active and inactive MMP-2 was not consistent, and no significance was 
noted among the groups. It might be that a longer culture or greater cell density, which 
was not selected in this study due to increased apoptosis, is needed to obtain a stronger 
difference in MMP-2 enzyme expression for the VICs. It should be noted that other 
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MMPs, such as MMP-1, 9, and 13 have been detected in diseased valve tissues [104], but 
only MMP-2 was detected in the VICs in this study. Our results are consistent with the 
literature since majority of VIC calcification studies measured only MMP-2 enzyme 
expression in VICs [103, 105, 106]. In fact, MMP-2 is the predominant ECM degrading 
enzyme expressed by VICs under most conditions [7], and expression of other MMPs in 
VICs in culture often requires their isolation from diseased tissues [107] or stimulation by 
growth factors and cytokines. Since no growth factor or cytokines were used in the 
osteogenic media, we could only detect the heavily expressed MMP-2 in this study. ECM 
remodeling is also associated with excessive synthesis of ECM proteins like GAGs [108]. 
Our results also showed increased GAG amount in noncoronary VICs compared with left 
and right coronary, confirming excessive matrix synthesis in the noncoronary cusp. 
VICs’ have been identified as a heterogeneous population in numerous cell culture 
and tissue-based studies. The mesenchymal progenitor VICs subpopulation has the ability 
to differentiate into osteoblast- or myofibroblast-like cells based on environmental cues 
or local mechanical stimuli [6]. In the present study, we showed for the first time that the 
osteogenic marker expression of the VICs and their ECM remodeling differ among the 
coronary and noncoronary aortic cusps. Heterogeneity of VICs according to their location 
within the aortic valve has been reported previously showing  that VICs from fibrosa 
layer demonstrated increased matrix remodeling and osteogenic markers compared to the 
ventricularis layers [108-113]. It was suggested that this is due to the different levels of 
cellular level strain experienced by VICs residing in each side of the cusp. VIC 
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phenotype analysis further showed that VICs in the fibrosa layer have a higher tendency 
to appear as myofibroblast- or osteoblast-like cells. On the other hand, VICs from the 
ventricularis layer showed greater potential for myofibroblast differentiation than those 
from the fibrosa layer in response to profibrotic stimuli in vitro suggesting that fibrosa 
VICs are inherently less sensitive to profibrotic signals [11]. Based on the present study, 
VICs from coronary cusps are inherently less responsive to osteogenic condition than 
noncoronary VICs.  
This study was limited by the fact that only early calcification markers, such as ALP 
and Runx2, could be detected in the osteogenic cultures. Since we chose not to use any 
calcification enhancing growth factors and cytokines, such as TGF-β, bone morphogenic 
proteins (BMPs), tumor necrosis factors (TNF)-α in our osteogenic media, a culture of 
minimum 21 days [31, 114] would likely be required to detect late calcification markers 
(osteocalcin, osteopontin etc.). Unfortunately, we had to limit our culture to 14 days to 
avoid excessive apoptosis in the VICs. This study also opens up questions regarding size 
of different cell population within each cusp. In addition to the local difference in 
mechanical forces due to the coronary inlets and mitral backflow, the embryonic origin of 
aortic valve cusps could predispose these VICs differently to calcification.  For example, 
cardiac neural crest cells (NCC) are uniquely distributed within the aortic valve during 
development, where majority of NCCs are present in left and noncoronary cusp [115]. 
Additionally, selective knockout of certain NCC markers reportedly results in abnormal 
aortic valve formation similar to bicuspid aortic valves [116]. It is possible that due their 
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embryonic origin, VICs from the left and noncoronary cusp will have elevated response 
to procalcific conditions than the right cusp. Unfortunately, the measurements reported in 
this study did not show any consistent trend between the left and right cusp. Further 
investigation is thus needed to discern the relationship between the VICs propensity 
towards osteogenic differentiation and the contributions of cellular embryonic origin and 
local mechanical stimuli.  
3.5 Conclusion 
In this study, we report a difference in the initiation of calcification of the VICs 
isolated from the coronary or noncoronary cusps. VICs isolated from noncoronary aortic 
cusps expressed elevated amount of osteogenic markers and greater matrix remodeling 
than VICs isolated from left and right coronary cusps. We also observed a positive 
correlation between the duration of osteogenic culture and calcification of the isolated 
VICs for all three aortic cusps. Furthermore, the above differences among the VICs were 
not due to an increased cell density in culture. Our results suggest that the VICs 
distributed among all three aortic valve cusps might be inherently different, or that a 
subpopulation of VICs predisposed to calcification might be present at varying density 
among the cusps. Further investigation is required to characterize the VICs’ different sub-
phenotypes throughout the aortic valve and to determine the role of local mechanical 
stimuli and cellular embryonic origin on VIC differentiation. 
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CHAPTER FOUR  
SEX-RELATED DIFFERENCES IN MATRIX 
REMODELING AND EARLY CALCIFIC MARKERS IN 
RAT AORTIC VALVULAR INTERSTITIAL CELLS  
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A version of this chapter is to be published as: 
Masjedi S, Lei Y, Ferdous Z. Sex-related differences in matrix remodeling and 
early calcific markers in rat aortic valvular interstitial cells, in preparation. 
 
Abstract: 
Calcific Aortic Valve Disease (CAVD) is a major cardiovascular disorder in the 
developed countries. Male is a known risk factor in this disease; unfortunately, how sex 
contributes to CAVD is mostly unknown. 
The objective of this study was to determine whether valvular interstitial cells 
(VICs) isolated from male versus female aortic valves demonstrate difference in 
calcification and/or extracellular matrix (ECM) remodeling. 
VICs were isolated from male and female rat aortic valves and cultured in 
osteogenic media for 10, 15 and 20 days. The proliferation among male and female VICs 
was assessed by a cell growth assay. The matrix remodeling of the VIC samples was 
quantified using glycosaminoglycan (GAG), collagen type I and gelatin zymography 
assays. Early calcific marker expression was assessed using alkaline phosphatase (ALP) 
staining and enzyme activity assay. Our result showed that proliferation of VICs was 
significantly greater in female than male after 12 days of culture in regular media. 
Additionally, male VICs showed greater amount of normalized GAG, collagen I, and  
activated matrix metallopreoteniase-2 expression compared to female. Similarly, ALP 
content was greater in male VICs than female at all time points. 
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The results from this research suggest that there is sex-related difference in the 
events associated with osteogenic differentiation of the aortic VICs, where male VICs are 
more prone to calcification. 
Keywords: Calcific aortic valve disease, valvular interstitial cells, sex-related 
differences, osteogenic differentiation 
 
 4.1 Introduction 
Aortic valve stenosis is the most common cause of valve replacement surgery in the 
US [12] and occurs at the advanced stage of calcific aortic valve disease (CAVD). CAVD 
is an active cell-mediated disorder mostly caused by ectopic calcification in the aortic 
valves [15]. Unfortunately, the underlying mechanisms of initiation and progression of 
CAVD are not fully understood. Furthermore, since sex is a major risk factor for CAVD, 
there is an urgency for a better understanding of this diseases’ pathology and role of key 
risk factors. 
Male sex has been identified as an independent risk factor for CAVD. Clinical 
reports have shown that male gender has two fold excess risk of aortic valve calcification 
[82]. Similarly, based on the Society of Thoracic Surgery risk scores, men have 19% 
higher relative rate of undergoing aortic valve replacement surgery due to aortic valve 
stenosis than women [117]. Several population-based studies highlighted differences in 
aortic valve calcification between male and female indirectly by concentrating on left 
ventricular hypertrophy due to pressure overload caused by aortic valve stenosis [118-
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121]. Furthermore, men appear to have more aortic valve calcium score and fibrosis 
thickening compared to women with aortic valve stenosis measured by Computer-
Tomography [38, 122]. Analysis of the longitudinal sections of the aortic valves in aged 
mice showed significantly thicker leaflets and higher degree of aortic regurgitation in  
male mice compared to  female [123]. The impact of sex on pathogenesis and progression 
of aortic valve stenosis at cellular and molecular levels thus needs to be investigated. 
Aortic valve calcification involves various mechanisms to interact with the residing 
cells within the aortic valve. There are two main cell types in the aortic valve: valvular 
endothelial cells (VECs), a cellular monolayer lining the outer surface of the valve cusps; 
and valvular interstitial cells (VICs), the dominant valve cell population that are 
distributed heterogeneously within the interstitial matrix [7]. At the initial stage of 
calcification, inflammation occurs due to VEC activation which triggers the extracellular 
matrix (ECM) remodeling and VIC differentiation. This is followed by expression of 
calcific markers such as alkaline phosphatase (ALP), Runx2, osteocalcin, and 
osteopontin, change in ECM proteins and enzymes such as glycosaminoglycan (GAGs) 
and matrix metalloproteinases (MMPs). The abnormal amount of calcific deposition 
within the ECM results in tissue stiffness and nodule formation as seen in stenotic valves. 
The role of sex/gender on non-valvular cardiovascular diseases has been contributed to 
the sex steroid hormones- mainly estrogen- and their receptors in the cardiovascular cells. 
β-Estradiol, the natural form of estrogen in human, was shown to have a protective effect 
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in women in heart valve diseases. Molecular mechanism of β-Estradiol contribution to 
VICs’ fate still remains unknown. 
In this study, we investigated whether the rat aortic valvular interstitial cells VICs 
isolated from male and female rat aortic valves show differences in matrix remodeling 
and early calcific markers when exposed to osteogenic culture conditions. We also 
assessed the VICs proliferation in the presence of β-Estradiol. We hypothesized that 
VICs isolated from each of the sexes would demonstrate different characteristics, where 
male VICs would demonstrate greater matrix remodeling and calcification compared to 
female VICs. 
4.2 Materials and methods 
4.2.1 Primary VIC isolation and culture  
Rat aortic valvular interstitial cells (RAVICs) were isolated and cultured from the 
aortic valves of freshly sacrificed 9-week-old male and female Sprague-Dawley rats 
(Envigo, formerly Harlan laboratory, Indianapolis, IN) using explant technique [17]. 
Briefly, the aortic valves were gently cut into 4-5 pieces and placed into a T25 culture 
plate and covered with a growth media consisting of DMEM, 10% FBS, 1% L-glutamine, 
and 1% Penicillin/Streptomycin (all purchased from Mediatech, Inc., Manassas, VA). 
The culture plates were then placed in cell culture incubators at 37
o
C and 5% CO2. At 
50% confluency, the valve pieces were removed, and the RAVICs were split into T75 
culture dishes . All cells were passaged at 90% confluency and used for experiments 
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between 6-7 passages. RAVICs were isolated from four different pairs of rat valves (n=4 
for each sex). 
Unless otherwise specified, the male and female RAVICs were seeded onto 6-well 
plates at a density of 250,000 cells/well. Osteogenic media consisted of 2.18 g/L beta-
glycerophosphate, 50 mg/L L-ascorbic acid 2-phosphate and 1mM dexamethasone (all 
purchased from Sigma) added to regular media. Experimental samples were cultured in 
osteogenic media, where the control wells were cultured in regular media. Culture 
duration was determined by preliminary studies where the RAVICs were cultured in 
osteogenic media for different time points ranging from 10 to 25 days. We noticed the 
RAVICs expressed strongest osteogenic markers at day 15 whereas by 21 days, we 
observed increased cell monolayer detachment possibly due to cell apoptosis. As a result, 
we selected day 20 as the longest calcification duration for this study. Further 
experiments were performed at 10, 15 and 20 day time-points. 
4.2.2 DNA content 
A colorimetric DNA assay was used to quantify the cell density of the male and 
female RAVICs [124]. Briefly, the cell pellets were digested in Proteinase-K solution 
(1mg/mL) (Sigma), followed by incubation of the cell lysates at a temperature between 
60
o
C and 70
o
C for 90 minutes in a water bath and then heating at >70
o
C for 30 minutes to 
denature the Proteinase-K. Hoechst 33258 dye (Sigma) was used to tag the released 
DNA. The fluorescence emission was measured using a BioTek H1 Fluoro-colorimeter at 
458 nm. Calf thymus DNA standards (Sigma) were used to calculate the DNA density. 
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4.2.3 Cell growth assay 
The rates of RAVICs growth for each sex were quantitatively determined as 
previously described [125]. Briefly, male and female RAVICs were seeded in separate 
12-well plates at a density of 10,000 cells/well and cultured for up to14 days in both 
regular and osteogenic culture media. The media was changed every 2 days. Every 2 
days, the cell populations were counted from triplicate wells using a hemocytometer 
(trypan blue exclusion).  
4.2.4 GAG content 
The GAG content was measured by adding a solution of Dymethylmethylene blue 
(DMMB) dye (Sigma) to the male and female RAVICs samples digested in Proteinase-K 
solution. The resulting absorbance was measured at 525 nm using a BioTeck H1 plate 
reader. The total GAG content in each sample was determined against chondroitin sulfate 
standards and normalized to total DNA content. 
4.2.5 Collagen type I content 
The collagen type I content was measured using a sirius red assay. The Proteinase-
K digested RAVICs samples were incubated with a sirius red dye (TCI) solution (0.3 
mg/ml, in 0.5M acetic acid) and then the supernatant was carefully collected from each 
sample after centrifugation at 6000 rpm for 30 minutes. The absorbance was measured at 
540 nm using a BioTek H1 plate reader. The collagen standards were prepared using 
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bovine dermal collagen type I (MP Biomedicals). The total collagen type I content was 
normalized to total DNA content. 
4.2.6 Gelatin zymography 
The amount of matrix metalloproteinase (MMP)-2, 9 enzyme produced by the 
RAVICs from each sex was determined using gelatin zymography. Briefly, equal 
amounts (5 mg of protein) of samples were ran through 10% zymogram gels, then 
renatured for 30 minutes and rinsed overnight in developing buffer at 37
o
C  (Life 
Technologies, Grand Island, NY). A colloidal blue staining kit (Life Technologies) was 
used to stain the gels followed by destaining in 30% ethanol/10% acetic acid for 10 
minutes and rehydration in 2% acetic acid for at least 15 minutes. The gels were imaged 
using a Bio-Rad ChemiDoc XRS imager, and the band densities were determined using 
Image J software. 
4.2.7 ALP staining and enzyme activity 
For ALP staining, the male and female RAVICs were fixed by a previously 
optimized mixture of citric acid, methanol and formalin [124]. Next, the fixed cell 
monolayers were stained with FRV-alkaline dye according to manufacturer’s protocol 
(Sigma 86R kit), followed by counter staining with diluted hematoxylin (1:1). The 
percentage of positively stained and total cells were calculated using the particles 
analyzing tool in Image J software. 
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To measure the ALP enzyme activity, the cultured RAVICs were homogenized in 
RIPA lysis buffer. 50 μM p-Nitrophenol solution (Sigma) was used to prepare standards. 
The samples were incubated with alkaline buffer (2-Amino-2-methyl-1-propanol, 
1.5mol/L, Sigma) and phosphatase substrate (p-Nitrophenyl phosphate, disodium, Sigma) 
for 30 minutes at 37
o
C. The reaction was stopped using 1mM sodium hydroxide solution, 
and the absorbance was measured at 405 nm using a BioTek H1 plate reader. The ALP 
amount in each sample was normalized to the total protein content determined using 
Pierce BCA Protein assay kit (Thermo Scientific) 
4.2.8 β-Estradiol treatment 
The male and female RAVICs were seeded separately in 12-well culture plates at a 
density of 10,000 cells/well and cultured in regular media prepared with phenol red-free 
DMEM (Life Technologies) for 24 hours. Next, the VICs were made quiescent by serum 
starvation for 48 hours in the above mentioned media without FBS. Lastly, the VICs were 
treated with media supplemented with different concentrations of β-Estradiol (0-40 
ng/ml) (Sigma) for 48hours. The cell numbers were counted in triplicate for each 
concentration of β-Estradiol by trypan blue exclusion using a hemocytometer. 
4.2.9 Statistical analysis 
Each experiment was repeated for three different cell isolations from each pair of 
rats (n=4). Statistical significance for the different experiments was obtained using 
single-factor ANOVA. A p-value of ≤0.05 was considered significant. 
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4.3 Results 
4.3.1 Comparable cell density between male and female RAVICs 
The DNA content of the cell lysates is an indicator of the cellular density. For each 
sex, there was no significant difference in the DNA content between calcified VICs in 
osteogenic media and their respective controls cultured in regular media for all time 
points (Figure 4.1 A and B for male and female VICs, respectively). Likewise, the DNA 
fold change of the RAVICs normalized to their respective controls was comparable 
among male and female for all time points (Figure 4.1C). 
4.3.2 Greater proliferation in female RAVICs compared to male 
Visual comparison of the VICs’ proliferation indicated similar confluency at the 
initial stage of culture (day 2) in female and male cells; however, after 12 days of regular 
culture female cells showed more confluency (Figure 4.2A). The cell growth  
measurements in regular and osteogenic media showed that osteogenic condition reduced 
cell growth for both male and female RAVICs as compared to regular media over time. 
Furthermore, female RAVICs showed significantly greater proliferation at 12 days in 
regular media as compared to male. No significant difference was seen among male and 
female RAVICs in osteogenic media (Figure 4.2B). 
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Figure  4.1 DNA content of VICs isolated from (A) male and (B) female rat aortic valves 
after 10, 15 and 20 days of culture in regular and osteogenic media. (C) comparison of 
DNA fold change for VICs cultured in osteogenic media normalized to their respective 
controls among male and female at all time points. Data represents mean ± std.error, n=4 
rat pairs. 
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Figure  4.2 (A) representative images of female and male VICs cultured for 2 and 12 days 
in regular media. Scale bar is 250μm. (B) Number of cells measured every 2 day for 
female and male VICs in both regular and osteogenic media with day 0 being the first day 
of osteogenic culture. The data represent mean ± std.error, n=2 rat pairs, *P < 0.05 
compared to male VICs in regular media at the same time point. 
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4.3.3 Elevated matrix remodeling in calcified male RAVICs compared with 
female 
The male RAVICs demonstrated significantly greater amount of total GAG content 
when normalized to their respective controls as compared with female after 10 and 15 
days of culture in osteogenic media. No significance was observed after 20 days of 
osteogenic culture although a difference was noticed (Figure 4.3A). The collagen type I 
content normalized to respective controls was significantly greater in male VICs than 
female at 15 days of culture in osteogenic media (Figure 4.3B). 
Evaluation of MMPs by gelatin zymography showed that VICs cultured in both 
regular and osteogenic media expressed pro-MMP-2 (inactive). Activated MMP-2, 
however, was present only in VICs cultured in osteogenic media. Expressed MMP-2 
bands for VICs isolated from male and female rat aortic valves after 15 days of culture is 
shown in Figure 4.4A, where top white lines correspond to pro-MMP-2 and bottom white 
lines to active MMP-2. After image analysis of the bands and normalizing to their 
respective controls, the amount of activated MMP-2 in male RAVICs was significantly 
elevated compared to female after 15 days of culture in osteogenic media (Figure 4.4B).  
However, no significance was seen in the inactive and total MMP-2 amounts between 
male and female VICs cultured in osteogenic media for 15 days. Similarly, no 
significance was seen in the active, inactive and total MMP-2 contents at 10 and 20 days 
of culture between male and female VICs (data not shown). MMP-9 bands were not 
detectable in this study. 
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Figure ‎4.3 Fold change in (A) GAG and (B) collagen type I content for VICs isolated 
from male and female rat aortic valves normalized to their respective controls after 10, 15 
and 20 days of osteogenic culture. The data represent mean ± std.error, n=4 rat pairs for 
GAG, n=3 rat pairs for collagen I, *P < 0.05 and P=0.07 compared to female VICs at the 
same time point. 
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Figure  4.4 MMP-2 expression in VICs isolated from male and female rat aortic 
valves after 15 days of culture; (A) representative gel image of control and calcified 
VICs, and (B) MMP-2 fold change (inactive, active, total) of VICs cultured in osteogenic 
media normalized to their respective controls. The data represent mean ± std.error, n=2 
rat pairs, *P < 0.05 compared to female VICs at day 15.  
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4.3.4 Elevated early calcific marker expression in male RAVICs as compared 
to female 
ALP staining of the VICs cultured in osteogenic condition showed that female cells 
did not stain positive for ALP at day 10 (Figure 4.5A); however, after 15 and 20 days of 
culture, the number of positive stained female cells increased (Figure 4.5B,C). On the 
other hand, male VICs stained positive at all time points (Figure 4.5D, E, F). The image 
analysis of ALP positive cells showed that the maximum percentage of positive stained 
cells occurred at day 15 of osteogenic culture for male VICs. Furthermore, the % ALP 
positive cells were significantly greater for male VICs than female at all time points 
(Figure 4.5G). The control VICs did not stain positive for ALP. Similarly, ALP enzyme 
activity measurement showed significantly greater amounts of ALP enzyme in male VICs 
in osteogenic media normalized to respective controls compared to female VICs at all 
time points; although the difference in ALP enzyme activity between male and female 
VICs was largest at day 10 of osteogenic culture (Figure 4.5H). 
4.3.5 Diminished proliferation of the female VICs due to β-Estradiol treatment 
Images of RAVICs showed that for both male and female, less cell growth was 
noticeable when β-Estradiol was added to the media after 2 days (Figure 4.6A). The cell 
number of female RAVICs decreased when treated with β-Estradiol for 2 days, and cell 
number decreased further in more concentrated β-Estradiol media. However, male 
RAVICs proliferation rate was not influenced by β-Estradiol (Figure 4.6B). 
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Figure ‎4.5 ALP expression measurements in female and male VICs after 10 (A,B), 15 
(C,D) and 20 (E,F) days of culture in osteogenic media. Scale bar is 100 μm (G) Image 
analysis show percent of ALP positive male and female VICs for day 10, 15 and 20, (H) 
Fold change in ALP enzyme activity of RAVICs cultured in osteogenic media for 10, 15 
and 20 days normalized to their respective controls measured by absorbance. The data 
represent mean ± std.error, n=2 rat pairs, *P < 0.05 compared to female RAVICs at the 
same time point. 
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Figure  4.6 (A) Images of male and female VICs treated with 0 and 20 ng/ml β-Estradiol 
in regular culture media for 2 days. Scale bar is 250μm. (B) number of male and female 
VICs treated with different concentrations of β-Estradiol ranging from 0 to 40 ng/ml for 2 
days. The data represent mean ± std.error, n=2 rat pairs. 
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4.4 Discussion  
In the present study, we showed that sex-related differences exist in the events 
associated with the osteogenic differentiation of VICs cultured in pathological condition. 
The highlights of this research are that VICs isolated from male aortic valves 
demonstrated greater amounts of matrix remodeling proteins (MMP-2) and excessive 
matrix synthesis (GAG, collagen I) after 15 days of culture in osteogenic media 
compared to female. Similarly, male VICs showed significantly elevated early calcific 
marker expression (ALP) compared to female VICs when cultured in osteogenic 
condition for 10, 15 and 20 days. Moreover, VICs isolated from female aortic valves 
showed greater proliferation than male when cultured for 12 days in regular media. 
Osteogenic culture condition seems to hinder proliferation for both male and female 
VICs. No significant difference was observed in DNA content of VICs cultured in 
osteogenic vs. regular media and male vs. female for each time point. This indicates that 
the observed differences in matrix remolding and calcific marker expression between the 
male and female aortic valves are not due to larger cell population. These results suggest 
that cellular-level differences among male and female VICs exist and may contribute to 
the excess risk of aortic valve calcification in male. 
It is well accepted that male is a significant risk factor for CAVD. Calcium deposits 
within the stenotic aortic cusps have been measured by computer-tomography calcium 
scoring, showing that men have greater aortic valve calcification score than women with 
similar aortic stenosis severity [38, 122]. This may be related to the more adaptive left 
 73 
 
ventricular response in women to the hypertrophy caused by aortic stenosis, which is an 
index for measuring the severity of aortic stenosis [32]. Similarly, calcium volume of the 
stenotic aortic valves was greater in aged men than women patients [126]. A study on the 
influence of sex on pathological changes performed on ApoE Knock-out aged mice 
reported increased thickness, acellularity, GAG transformation and fibrosis of the 
spongiosa layer in male aortic leaflets compared to aged female mice; however, no 
valvular calcification in ApoE or wildtype mice was observed [123]. Another work on 
genetic evaluation of the sex-related differences in aortic valves has identified 183 genes 
to be significantly different among male and female VICs isolated from healthy porcine 
aortic valves, where few of these genes contribute to the pathways associated with CAVD 
[39]. Our study, for the first time, showed that there are sex-related differences in early 
osteogenic differentiation of the aortic valves at the cellular level. 
In a normal aortic valve cusp, majority of VICs are a quiescent sub-phenotype of 
fibroblasts [11, 127]. A small population of mesenchymal progenitor VICs exists with 
differentiation capability into myofibroblasts or osteoblast-like cells. In aortic valve 
injuries, the mesenchymal progenitor VICs become activated and proliferate to repair the 
valve [6, 7]. Our results show that in regular culture condition, female RAVICs 
proliferate faster than male. It can be inferred that male VICs are inherently less prone to 
proliferation. Previous studies associated VICs’ proliferation to aortic valve calcification; 
however, VICs used in these studies were isolated from stenotic or aged patients [128], or 
cytokines like Interleukin-1 beta (IL-1β) [129] were added to the VICs. Our results 
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confirmed that osteogenic culture inhibited VICs’ proliferation regardless of the sex of 
the cells. 
Matrix remodeling, excessive ECM protein synthesis and calcific markers 
expression are hallmarks of calcific aortic valves. MMP-2 is the major matrix degrading 
enzyme that is abundantly expressed among calcified VICs [13]. In our study, VICs 
isolated from male rat aortic valves showed significantly elevated expression of activated 
MMP-2 compared to female after 15 days of culture in osteogenic media. However, the 
amounts of inactive and total MMP-2 among male and female VICs were comparable. 
Furthermore, longer osteogenic culture duration of 20 days did not show significant 
difference in any type of MMP-2 (active, inactive, total) among male and female VICs 
possibly due to apoptosis. Larger cell density might be required to obtain greater 
difference in MMP-2 expression among male and female VICs. In calcific valves, matrix 
deposition and fibrosis have also been reported where activated VICs produce excessive 
collagen I, proteoglycans and other matrix proteins [130]. Our results showed greater 
amounts of normalized GAG and collagen I contents in male RAVICs compared to 
female cultured in osteogenic media, indicating elevated matrix remodeling in activated 
male RAVICs.  
Osteogenic differentiation of aortic VICs is associated with calcific marker 
upregulation. ALP is often detected in VICs isolated from diseased aortic valves [14] or, 
when cultured in pathological conditions [124]. Our study showed that amounts of ALP 
enzyme and percent ALP positive cells were significantly greater in VICs isolated from 
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male rat aortic valves than female for all time points of osteogenic culture. This suggests 
that male VICs might be more prone to osteogenic differentiation in pathological 
condition. 
At the cellular level, every cell in the body has a sex due to chromosomal 
complements that define the sex. Estrogen Receptors (ERs) subtypes are a member of 
intracellular receptor family known as the nuclear ligand-activated transcription factors. 
ER-α and -β and GPER (G-protein coupled estrogen receptor) located on the plasma 
membrane are present in both human vascular smooth muscle cells [131, 132] and 
endothelial cells [133, 134]. Through binding to ERs, the natural estrogen β-Estradiol 
demonstrated regulatory effects in the vascular cells, as previously reviewed [135]. 
Examples include rapid generation of Nitric Oxide (NO) in the endothelial cells that has 
anti-inflammatory and vasodilatory effects in vasculature [136], or modulation of Ca
2+
 
ion channel mobilization on smooth muscle cells [137]. Sex-related differences of 
cultured vascular smooth muscle cells have been studied in response to NO exposure [68] 
or UV radiation to stimulate atherosclerotic condition [138]; likewise, sex-related 
differences in their ability of ECM production and remodeling and proliferation have 
been tested when treated with β-Estradiol [139]. In this study, we measured sex-related 
difference of β-Estradiol treatment on RAVICs. Our results showed that β-Estradiol 
decreased the cell proliferation in female RAVICs indicating an inhibitory effect on 
female VICs proliferation. However, β-Estradiol appeared to have no effect on male 
VICs proliferation. 
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Limitations of this study include VICs from aged rats were not used for sex-related 
difference assessment. In fact, we isolated VICs from aged male and female rats 
(Appendix, Figure Ap.3A,B); however, we were not able to grow the aged cells to a large 
population possibly due to low proliferation ability of the older cells and the small size of 
the aortic valve in a rat heart. Coating of the culture plates with gelatin or collagen I and 
using growth factors are potential solutions that we did not use in this study to be 
coherent with the results from young VICs; however, can be used for future 
investigations. Another limitation is the inability to detect late calcific markers. A larger 
cell density or adding of a calcification promoter like Tgf-β might be required to obtain 
late calcific markers. Unfortunately, we did not use lager cell density or growth factors to 
avoid apoptosis. Furthermore, no nodule formation or mineralization was observed within 
both male or female VICs at all times of osteogenic culture. The latter opens up 
possibilities for comparative studies on calcification among different species. Another 
limitation is that we did not test the effect of other hormones like dihydrotestosterone or a 
cocktail of hormones on VICs. Unfortunately, our laboratory has limitations regarding 
use of certain hormones like dihydrotestosterone. 
4.4 Conclusion 
In this study, we report sex-related differences among VICs isolated from male 
versus female rat aortic valves in the events associated with osteogenic differentiation. 
Male VICs demonstrated greater matrix remodeling and elevated amounts of early 
calcific markers than female VICs when cultured in pathological condition. The above 
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differences were not due to differences in cell density among male and female. We also 
observed an inhibitory effect of β-Estradiol on female VICs proliferation only. Our 
results suggest that there is cellular differences within the male and female aortic valves. 
A subpopulation of VICs that is predisposed to osteogenic differentiation might exist at 
varying density within male and female aortic valves that causes these differences, or the 
density of estrogen receptors in male and female VICs might be inherently different. 
Further investigations are required to assess the VICs inherent characteristics or to 
quantify different subpopulations within male and female aortic valves. 
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CHAPTER FIVE  
CALCIFICATION POTENTIAL OF AORTIC VALVULAR 
INTERSTITIAL CELLS UNDER CYCLIC STRAIN 
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In chapter 3, I presented a comparative study on calcification of the VICs isolated 
separately from coronary and noncoronary cusps of porcine aortic valves. I found that 
VICs isolated from noncoronary cusps demonstrate greater calcification potential 
compared to coronary cusps. In chapter 4, I investigated the sex-related differences in 
osteogenic differentiation among VICs isolated from male and female rat aortic valves. I 
identified that male VICs represent greater ECM remodeling and early calcification than 
female. In the present chapter, I tested both hypotheses under cyclic strain to verify 
whether the VICs’ calcification will be enhanced between male and female or among 
different aortic cusps. 
For evaluation the male and female RAVICs’ calcification under cyclic strain, I 
have primary contribution to all the steps of designing and performing the experiments, 
analyzing the results, and writing the manuscript. In the second part for testing PAVICs’ 
calcification from different aortic cusps under cyclic stretch, the experiments were 
performed in collaboration with another graduate student from our lab.  
 
5.1 Introduction 
 Aortic valve disease is a major cardiovascular disorder that affects approximately 
28% of the elderly population. It has been well established that male sex is a risk factor 
for aortic valve disease [140]. However, the underlying mechanism relating male sex to 
increased aortic valve calcification remains unclear. In addition to sex, several studies 
have shown a direct relationship between hypertension and aortic valve disease. 
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It has been shown that normal aortic valves constantly interact with the enforced 
mechanical forces  in each systolic cycle. The inhabitant aortic VICs characteristics vary 
due to hemodynamic changes. Previous studies on tissue [110, 141] or cultured VICs [30] 
have shown that cyclic strain contribute to the VIC differentiation and remodeling; where 
at abnormal levels VICs demonstrate elevated calcification. 
In the present study, we aim to determine if the aortic VICs isolated from male and 
female rats develop different amounts of calcification when cultured under representative 
physiological (10%) or pathological (15%) levels of cyclic strain. Additionally, we will 
test whether VICs isolated from different aortic cusps of porcine valves demonstrate 
different amount of calcification under cyclic strain in osteogenic media. The results from 
this study would provide crucial information at cellular level to understand if the VICs 
isolated from different sex or aortic cusps demonstrate different amounts of calcification 
under cyclic stretching. 
5.2 Materials and Methods 
5.2.1 VIC isolation 
For RAVICs, 9 week old Male and Female Sprague-Dawley rats were purchased 
from Harlan laboratory. The cell isolation was identical to part 4.2.1. Briefly, the rats 
were euthanized using CO2 inhalation and the aortic valves were removed from the rat 
hearts using a dissecting microscope. Each aortic valve was carefully cut into 5-6 pieces, 
then placed into a culture plate and covered with media consisting of DMEM, 10% FBS, 
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1% l-glutamine and 1% penicillin/streptomycin (Mediatech). The VICs from each sex 
were used for experiments at passage 7. 
For PAVICs, aortic valves of 4-5years old pigs were used for cell isolation. PAVIC 
isolation process is identical to part 3.2.1. Briefly, aortic valves were dissected and 
PAVICs were isolated by collagenase digestion from each cusp separately. The cells 
were passaged at 90% confluency and used for experiments at 4 passages. 
5.2.2 Culture under cyclic strain 
In order to study the effect of cyclic strain on calcification, the RAVICs and 
PAVICs were plated in collagen-I coated Bioflex® 6-well culture plates. First, the cells 
were cultured under static condition for two days for the cells to adhere to the plates. For 
experimental samples, calcifying culture media was then added consisting of beta-
glycerophosphate, ascorbic acid and dexamethasone in regular culture medium. The 
culture plates were then placed into a commercial Flexcell® system (Flexcell 
International Inc.) and stretched under 10% and 15% cyclic stretching. The controls wells 
under stretch and static controls were cultured in regular media. All the samples were 
collected for analysis after 7 days of stretching.  
5.2.3 Alizarin red S staining 
Calcific nodule formation and calcium precipitation was determined for each 
sample using Alizarin red S staining [124]. First, the RAVICs and PAVICs were fixed 
with 10% formalin and treated with alizarin red solutions at room temperature for 4 to 5 
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minutes. The excess dye was washed off, and then the VICs were dehydrated with 100% 
acetone for less than 1 minute. The stained samples were finally imaged at 10X 
magnification; image analysis was performed using ImageJ software. For image analysis, 
an average number of 36 images per well were imported into Image J. The color channel 
on each image was split, and the threshold was adjusted to form a black and white image. 
Finally, the area, area fraction, integrated density, and perimeter of each image were 
measured.  
5.2.4 ALP enzyme activity assay 
The RAVICs were assessed for ALP upregulation using an ALP enzyme activity 
assay. The steps were similar to part 3.2.6. Briefly, the cell layers were lysed in 400μm 
RIPA buffer, a dye solution of 221 Alkaline buffer and phosphatase substrate (both from 
Sigma) was added to the samples and the resulting absorbance was measured at 405 nm 
using a BioTek H1 plate reader. The total ALP enzyme was normalized to protein content 
measured using BCA assay (kit purchased from Fisher Scientific, data not shown here). 
5.2.5 statistical analysis 
Statistical significance was determined using one-way ANOVA. A p-value of ≤0.05 was 
considered significant. 
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5.3 Results 
5.3.1 Greater nodule formation and nodule size in male RAVICs than female 
under pathological cyclic strain 
The calcified nodules in RAVICs stained by alizarin red S show greater amount of 
calcific deposition in male than female. Figure 5.1A shows representative images of 
calcific nodules in male and female RAVICs cultured under 10% and 15% cyclic strain 
for 7 days in osteogenic media. We found that the nodule parameters were significantly 
greater for pathological strain (15%) only in male RAVICs. Moreover, the normalized 
percentage of area covered with calcific nodules and normalized integrated density to 
their respective static controls in osteogenic media were significantly greater for male 
RAVICs compared to female (Figure 5.1 B,C). Similarly, the normalized nodule size to 
static control in osteogenic media was greater in male RAVICs compared to female under 
pathological strain (15%) after 7 days in osteogenic media. Interestingly, the pathological 
strain increased the size of the nodules for both female and male RAVICs compared to 
physiological strain. We did not observe any nodule formation in the controls under all 
levels of strain in regular media. 
5.3.2 Elevated early calcific marker expression in male RAVICs compared to 
female under pathological cyclic strain 
The ALP enzyme activity increased under pathological strain (15%) for both 
female and male RAVICs, however the normalized ALP content in RAVICs under  
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Figure ‎5.1 (A) Calcific nodules in male and female VICs as measured using alizarin red 
staining. Scale bar is 100 μm. greater normalized nodule (B)area percentage(C) integrated 
density and (D) size in male RAVICs compared to female under 15% cyclic strain. data 
represent mean ± std. error, n=2 rat pairs. ⃰ indicates p<0.05 compared to female. 
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pathological strain was greater in male RAVICs compared to female to respective 
controls in static condition after 7 days in osteogenic media (Figure 5.2). Moreover, our 
data for control samples under cyclic stretch cultured in regular media for 7 days show 
expression of ALP enzyme in all the samples, however male controls showed increased 
amounts of ALP enzyme compared to female at similar levels of strain (data not shown).  
 
 
Figure  5.2 Fold change in ALP enzyme activity under 10 and 15% cyclic strain 
normalized to respective controls in static condition after 7 days in osteogenic media. The 
data represents mean ± std. error. 
 
5.3.3 Greater calcification in PAVICs isolated from noncoronary cusps under 
pathological cyclic strain 
Alizarin red S staining of the calcified nodules among PAVIC monolayers after 
being stretched for 7 days in osteogenic media showed that calcific nodules were formed 
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in all the PAVICs from left, right and non-coronary under both physiological and 
pathological levels of strain. Figure 5.3A and B show representative images of nodules in 
PAVICs isolated from each aortic cusp and cultured under 15% stretch in osteogenic 
media. Moreover, no nodules were formed in respective controls under strain in regular 
media; however, nodules were observed in controls in static condition. The noncoronary 
PAVICs showed increased nodule area percentage and integrated density normalized to 
their respective statin control in osteogenic media under both physiological (10%) and 
pathological cyclic strain (Figure 5.3C,D).  
5.4 Discussion  
 In this study, we observed that male VICs form greater amount of calcific nodules 
compared to female VICs under pathological levels of cyclic stretch. The nodule 
formation is an indicator of early cell accumulation, which triggers cell differentiation 
into diseased phenotypes. Similarly, male VICs demonstrated elevated ALP enzyme 
expression compared to female under pathological levels of strain.  
Aortic valve cusps are in direct contact with the high-pressure blood flow pumped 
out of the left ventricle; Additionally, after the valve closes that blocks the blood 
backflow into the ventricle, high pressure is applied to the aortic cusps. At both stages, 
aortic cusps are stretched which subjects residing VICs to cyclic strain. 
Our results support than male is at higher risk of calcification than female, and this 
risk is greater under pathological stretch as observed in hypertension. Further  
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Figure  5.3 (A) Representative images of stained nodules in VICs isolated from left, right 
and noncoronary aortic cusps under 15% cyclic strain for 7 days in osteogenic media. 
Scale bar is 250μm. (B) single nodules of left, right and noncoronary VICs under 15% 
cyclic strain. scale bar is 100μm. (C) Fold change in area percentage and (D) nodule size 
o VICs from left, right and noncoroanry aortic cusps cultured under 10 and 15% cyclic 
strain in osteogenic media normalize to respective static control. The data represent mean 
± std. error. 
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investigation on these cell types is required to fully understand the interplay between sex 
and cyclic stretch in aortic valve disease. 
  
 89 
 
CHAPTER SIX  
CONCLUSIONS AND SUMMARY 
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Studying the calcific aortic valve disease (CAVD) on different levels has recently 
gained considerable attention. This is due to interesting characteristics of the aortic valves 
and CAVD’s pathogenesis: first, the aortic valve cusps have a highly complicated 
structure within a very small thickness. Three thin layers- Fibrosa, Spongiosa, and 
Ventricularis- have varying amounts of collagen fibers and cell densities, each with a 
specific role in aortic valve function. Second, the VICs in the adult aortic valve have a 
heterogeneous population. A certain sub-phenotype (mesenchymal progenitor VICs) 
show differentiation capabilities into osteoblast-like cells under pathological condition. 
Third, CAVD has prominent risk factors with extensive prevalence like age, male sex, 
renal disease, etc. The knowledge on the pathological mechanism linking these risk 
factors to CAVD progression is very limited. Particularly the molecular biology behind 
contribution of male sex to greater risk of this disease remains unknown. Fourth, aortic 
valves are anatomically located in a very dynamic environment. The highest number of 
clinical heart valve disorders in human belongs to aortic valve. Aortic valve cusps are in 
direct contact with the high-pressure blood flow which subjects residing VICs to cyclic 
strain at each systole and diastole. 
Male is a risk factor in a number of major cardiovascular diseases; however, limited 
research have been performed to understand the molecular and cellular mechanisms 
exposing male to greater risk of cardiovascular disorders. In chapter 2, the previous 
studies on sex-related differences in aortic stenosis, mitral valve prolapse and 
atherosclerosis have been reviewed. We learned that aortic valve stenosis and 
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atherosclerosis share number of major characteristics such as activation of endothelial 
cells and macrophage infiltration at the initial stages, osteogenic differentiation into 
osteoblast-like cells, etc. 
In chapter 3, the difference in calcification among individual aortic cusps was 
determined at a cellular level. It is known that noncoronary cusp and commissures are the 
preferred site for CAVD initiation. VICs were isolated separately from porcine aortic 
cusps and cultured in osteogenic condition for up to 14 days, then calcific markers 
expression and ECM remodeling were measured for each group. We found that VICs 
isolated from noncoronary cusps demonstrated greater calcific markers expression and 
nodule formation. In addition, elevated ECM remodeling enzymes were present within 
noncoronary VICs. We suggest that there might be an inherent different in the VICs 
characteristics in each aortic cusp or a subpopulation of VICs that is predisposed to 
calcification might be present at different densities among coronary and noncoronary 
cusps. 
In chapter 4, the greater risk of aortic valve calcification in male sex was assessed 
at a cellular level. To our knowledge, this is the first study to assess the cellular 
differences between male and female in the events associated with aortic valve 
calcification. VICs were isolated from male and female rat aortic valves and cultured in 
osteogenic media for up to 20 days. Our results confirmed the hypothesis that sex-related 
differences exist between the male and female VICs cultured in pathological condition. 
The VICs isolated from male aortic valves showed greater amounts of matrix synthesis 
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and remodeling. Moreover, early calcific markers were upregulated in male VICs more 
significantly than female. Neither of the male or female VICs showed nodule formation 
or mineral deposition even after 20 days of osteogenic culture. We suggest that VICs in 
male or female aortic valves might be inherently different, or maybe the different heart 
sizes between male and female enforce greater mechanical forces to male and cause 
different cell densities of VIC sub-phenotypes between male and female. 
In chapter 5, we tested both studies of the previous chapters under cyclic strain to 
verify whether application of cyclic strain enhances the calcification of the VICs and the 
differences observed in the previous studies. VICs isolated from male and female rat and 
porcine aortic valves were cultured in collagen I-coated Bioflex® culture plates and 
subjected to physiological (10%) and pathological (15%) cyclic stretch using a flexcell® 
system. Our results showed increased calcific marker expression in male VICs after 
normalizing to respective controls cultured in static condition in osteogenic media for 
similar length of time (7 days). In addition, control samples that were under similar cyclic 
strain and in regular media showed no nodule formation. It is confirmative that 
pathological levels of cyclic stretch enhances the calcification of male VICs more 
significantly than female when cultured in osteogenic media. We suggest that 
pathological cyclic strain individually does not initiate the VICs osteogenic 
differentiation where there are no biochemical factors in the environment. We conclude 
that calcification of VICs in the native tissue might be caused by combination of 
pathological mechanical forces and inflammatory or degenerative enzymes in the ECM. 
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This dissertation provides comparative studies on VICs calcification potential from 
different aortic valve locations or sexes. Research presented in this dissertation could 
have great impact on analyzing the molecular events associated with aortic valve 
calcification, providing differences on the VICs characteristic where no growth factor 
was added to the cells to elevate the calcification. The results provided in this dissertation 
can change the experimental approaches in the studies on aortic valve calcification, and 
in the future, necessitate different treatments for CAVD patients based on their gender 
and clinical history. 
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In chapter 4, it was mentioned that no nodule formation or mineral deposition were 
observed within the VICs isolated from male or female rat aortic valves even after up to 
20 days of culture in osteogenic media. We decided to repeat the tests for VICs isolated 
from male and female porcine aortic valves. VICs isolation and culture methods were 
similar to part 3.2.1. Next, the male and female PAVICs were stained for alizarin red S 
and Von Kossa using methods similar to part 3.2.4. Our results showed nodule formation 
and mineral deposition in PAVICs from both sexes. 
Images of male and female VICs from rat and porcine aortic valves stained for Von 
Kossa indicated that mineral deposition occurs in porcine VICs and not in rat VICs 
(Figure Ap.1). 
Images of male and female rat and porcine VICs stained for alizarin red S 
demonstrated the abundance of calcific nodules within porcine VICs; however no 
nodules was formed in rat VICs (Figure Ap.2). 
This project is still ongoing; however the results we obtained so far suggest that 
there might be a difference among species in the events associated with aortic valve 
calcification. Further investigation is required to confirm this hypothesis. 
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Figure ‎6.1 Mineral deposition among male and female VICs isolated from rat and porcine 
aortic valves after 15 days of culture in osteogenic media. Scale bar is 250μm. 
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Figure ‎6.2 Calcific nodules among male and female VICs isolated from rat and porcine 
aortic valves after 15 days of culture in osteogenic media. Scale bar is 250μm. 
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In chapter 4, it was mentioned that VICs have also been isolated and cultured from 
aged rats (30 weeks); however, they did not grow to a large population and stopped 
growing after 3 passages. Therefore, we were not able to perform the experiments on 
aged VICs to determine their calcification. Figure Ap. 3A,B show representative images 
of the female and male aged rat VICs, respectively. 
 
 
 
Figure ‎6.3 Representative images of VICs isolated from (A) female and (B) male aged rat 
aortic valves after 2 passages. Scale bar is 250μm. 
 
  
 121 
 
VITA 
 
Shirin Masjedi was born in Tehran, the capital city of Iran. She finished her high 
school education in the National Organization for Development of Exceptional Talents 
(NODET) in Tehran. She graduated from Ferdowsi University of Mashhad with a BS in 
Materials Science and Engineering. She continued her graduate studies at Amirkabir 
University of Technology and obtained a MS degree in Biomedical Engineering. She 
moved to US in January 2012 to attend the University of Tennessee-Knoxville towards a 
PhD degree in Biomedical Engineering. Since then, she has been working in Dr. Zannatul 
Ferdous’ laboratory. Her research is focused on cardiovascular engineering. She has 
published papers in peer-reviewed journals and presented in number of major national 
conferences. She also have three Iranian patents. 
 
 
